Source: BioSpace

Hi-Tech Pharmacal: Hi-Tech Pharmacal Invalidates Five Beta-Alanine, CarnoSyn, Patents Held By

Life Sciences Jobs ...

Read full article »
Hi-Tech Pharmacal's Competitors | Hi-Tech Pharmacal's News | Hi-Tech Pharmacal's Financials
Stay up-to-date with the latest news on Hi-Tech Pharmacal
Est. Annual Revenue
$100-500M
Est. Employees
250-500
David S. Seltzer's photo - President & CEO of Hi-Tech Pharmacal

President & CEO

David S. Seltzer

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Hi-Tech Pharmacal